Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Abdom Radiol (NY)
1 Ann Fam Med
1 BMB Rep
1 Bratisl Lek Listy
1 Can Urol Assoc J
1 Cancer Treat Rev
1 Carcinogenesis
1 Cell Physiol Biochem
1 Cent European J Urol
1 Clin Cancer Res
1 Clin Chim Acta
1 Clin Genitourin Cancer
1 Clin Immunol
1 Clin Oncol (R Coll Radiol)
1 Diagn Cytopathol
1 Diagn Pathol
1 Gene
1 Int J Nanomedicine
1 Investig Clin Urol
1 Iran J Med Sci
1 J Clin Pathol
1 J Control Release
1 J Environ Sci (China)
1 J Trace Elem Med Biol
1 Lancet
1 Med Clin North Am
1 Medicine (Baltimore)
1 Mol Cell Biochem
1 Mol Med Rep
1 Nat Rev Urol
1 Oncol Lett
1 Oncol Res
1 Oncotarget
1 PLoS One
1 Strahlenther Onkol
2 Support Care Cancer
4 Urol Oncol

    Abdom Radiol (NY)

  1. RAZIK A, Das CJ, Sharma S, Seth A, et al
    Diagnostic performance of diffusion-weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: utility of evaluating the morphology of the reactive tumor stalk.
    Abdom Radiol (NY). 2018 Feb 1. pii: 10.1007/s00261-018-1458.
    >> Share

    Ann Fam Med

  2. FARLEY A, Koshiaris C, Oke J, Ryan R, et al
    Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer.
    Ann Fam Med. 2017;15:443-450.
    >> Share

    BMB Rep

  3. ROH YG, Mun MH, Jeong MS, Kim WT, et al
    Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.
    BMB Rep. 2018 Feb 5. pii: 4050.
    >> Share

    Bratisl Lek Listy

  4. ALIVAND M, Soufi RT, Madani AH, Esmaeili SN, et al
    Histonedeacetylase 1 mRNA has elevated expression in clinical specimen of bladder cancer.
    Bratisl Lek Listy. 2018;119:12-16.
    >> Share

    Can Urol Assoc J

  5. SAYYID RK, Sayyid AK, Klaassen Z, Hersey K, et al
    Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives.
    Can Urol Assoc J. 2018 Feb 6. pii: cuaj.4922. doi: 10.5489/cuaj.4922.
    >> Share

    Cancer Treat Rev

  6. MASSARI F, Di Nunno V, Cubelli M, Santoni M, et al
    Immune checkpoint inhibitors for metastatic bladder cancer.
    Cancer Treat Rev. 2018;64:11-20.
    >> Share


  7. JIANG G, Huang C, Li J, Huang H, et al
    Transcriptional and Posttranscriptional Upregulation of p27 Mediates Growth Inhibition of Isorhapontigenin (ISO) on Human Bladder Cancer Cells.
    Carcinogenesis. 2018 Feb 2. pii: 4834629. doi: 10.1093.
    >> Share

    Cell Physiol Biochem

  8. LI C, Zeng X, Liu Z, Li F, et al
    BDNF VAL66MET Polymorphism Elevates the Risk of Bladder Cancer via MiRNA-146b in Micro-Vehicles.
    Cell Physiol Biochem. 2018;45:366-377.
    >> Share

    Cent European J Urol

  9. JOBCZYK M, Pikala M, Rozanski W, Maniecka-Bryla I, et al
    Years of life lost due to bladder cancer among the inhabitants of Poland in the years 2000 to 2014.
    Cent European J Urol. 2017;70:338-343.
    >> Share

    Clin Cancer Res

  10. WANG WJ, Li CF, Chu YY, Wang YH, et al
    Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
    Clin Cancer Res. 2017;23:503-513.
    >> Share

    Clin Chim Acta

  11. LIN Y, Wang Y, Wu Q, Jin H, et al
    Association between obesity and bladder cancer recurrence: A meta-analysis.
    Clin Chim Acta. 2018;480:41-46.
    >> Share

    Clin Genitourin Cancer

  12. KLAASSEN Z, Goldberg H, Chandrasekar T, Arora K, et al
    Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level Analysis.
    Clin Genitourin Cancer. 2018 Jan 5. pii: S1558-7673(18)30004.
    >> Share

    Clin Immunol

  13. WU K, Tan MY, Jiang JT, Mu XY, et al
    Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
    Clin Immunol. 2018 Feb 1. pii: S1521-6616(17)30473.
    >> Share

    Clin Oncol (R Coll Radiol)

  14. KILTIE AE, Southby R, LeMonnier K, Binnee J, et al
    High Levels of Patient Satisfaction in Joint Uro-oncology Clinics to Assist Patient Choice in Early Prostate Cancer and Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2018 Jan 25. pii: S0936-6555(18)30006.
    >> Share

    Diagn Cytopathol

  15. VIRK RK, Abro S, de Ubago JMM, Pambuccian SE, et al
    The value of the UroVysion(R) FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
    Diagn Cytopathol. 2017;45:481-500.
    >> Share

    Diagn Pathol

  16. KWON JE, Cho NH, Choi YJ, Lim SD, et al
    Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea.
    Diagn Pathol. 2017;12:54.
    >> Share


  17. WANG W, Li C, Chen Y, Teng L, et al
    Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis.
    Gene. 2018 Feb 2. pii: S0378-1119(18)30127-6. doi: 10.1016/j.gene.2018.
    >> Share

    Int J Nanomedicine

  18. QIU X, Cao K, Lin T, Chen W, et al
    Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Int J Nanomedicine. 2017;12:7365-7374.
    >> Share

    Investig Clin Urol

  19. KIM JK, Cho MC, Ku JH, Paick JS, et al
    Preperitoneal placement of an inflatable penile prosthesis reservoir for postoperative erectile dysfunction after radical cystoprostatectomy with orthotopic neobladder.
    Investig Clin Urol. 2016;57:364-6.
    >> Share

    Iran J Med Sci

  20. AGHAMOHAMMADI D, Gargari RM, Fakhari S, Bilehjani E, et al
    Classic versus Inguinal Approach for Obturator Nerve Block in Transurethral Resection of Bladder Cancer under Spinal Anesthesia: A Randomized Controlled Trial.
    Iran J Med Sci. 2018;43:75-80.
    >> Share

    J Clin Pathol

  21. HODGSON A, Xu B, Satkunasivam R, Downes MR, et al
    Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    J Clin Pathol. 2018;71:154-160.
    >> Share

    J Control Release

  22. GUO H, Xu W, Chen J, Yan L, et al
    Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma.
    J Control Release. 2017;259:136-148.
    >> Share

    J Environ Sci (China)

  23. XU T, Yin J, Chen S, Zhang D, et al
    Elevated 8-oxo-7,8-dihydro-2'-deoxyguanosine in genome of T24 bladder cancer cells induced by halobenzoquinones.
    J Environ Sci (China). 2018;63:133-139.
    >> Share

    J Trace Elem Med Biol

  24. WACH S, Weigelt K, Michalke B, Lieb V, et al
    Diagnostic potential of major and trace elements in the serum of bladder cancer patients.
    J Trace Elem Med Biol. 2018;46:150-155.
    >> Share


  25. CATTRINI C, Boccardo F
    Atezolizumab and bladder cancer: facing a complex disease.
    Lancet. 2018;391:305-306.
    >> Share

    Med Clin North Am

  26. ARORA HC, Fascelli M, Zhang JH, Isharwal S, et al
    Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist.
    Med Clin North Am. 2018;102:231-249.
    >> Share

    Medicine (Baltimore)

  27. LI H, Liu L, Shi Q, Stemmer A, et al
    Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.
    Medicine (Baltimore). 2017;96:e9292.
    >> Share

    Mol Cell Biochem

  28. PRESLER M, Wojtczyk-Miaskowska A, Schlichtholz B, Kaluzny A, et al
    Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer.
    Mol Cell Biochem. 2018 Feb 2. pii: 10.1007/s11010-018-3306.
    >> Share

    Mol Med Rep

  29. LIAO G, Chen F, Zhong J, Jiang X, et al
    MicroRNA539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF1R.
    Mol Med Rep. 2018 Jan 25. doi: 10.3892/mmr.2018.8497.
    >> Share

    Nat Rev Urol

  30. THOMA C
    Bladder cancer: Improving NMIBC risk stratification.
    Nat Rev Urol. 2018 Feb 6. pii: nrurol.2018.13. doi: 10.1038/nrurol.2018.
    >> Share

    Oncol Lett

  31. ASAI S, Miura N, Sawada Y, Noda T, et al
    Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.
    Oncol Lett. 2018;15:522-527.
    >> Share

    Oncol Res

  32. WU H, Wang X, Mo N, Zhang L, et al
    B7-homolog 4 promotes epithelial-mesenchymal transition and invasion of bladder cancer cells via activation of nuclear factor-kappaB.
    Oncol Res. 2018 Feb 1. doi: 10.3727/096504018X15172227703244.
    >> Share


  33. LI X, Wang W, Zhu G, He W, et al
    Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.
    Oncotarget. 2017;9:2782-2796.
    >> Share

    PLoS One

  34. SATHE A, Chalaud G, Oppolzer I, Wong KY, et al
    Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.
    PLoS One. 2018;13:e0190854.
    >> Share

    Strahlenther Onkol

    [Complications instead of improved survival and local freedom from recurrence after early radical cystectomy in muscle-invasive bladder cancer compared to multimodal maintenance therapy].
    Strahlenther Onkol. 2018 Feb 2. pii: 10.1007/s00066-018-1274.
    >> Share

    Support Care Cancer

  36. YANG YL, Li MY, Liu L, Wang L, et al
    Perceived stress and its associated demographic-clinical characteristics and positive expectations among Chinese cervical, kidney, and bladder cancer patients.
    Support Care Cancer. 2018 Feb 5. pii: 10.1007/s00520-018-4081.
    >> Share

  37. RUTHERFORD C, Patel MI, Tait MA, Smith DP, et al
    Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.
    Support Care Cancer. 2018 Feb 1. pii: 10.1007/s00520-018-4058.
    >> Share

    Urol Oncol

  38. GODWIN JL, Hoffman-Censits J, Plimack E
    Recent developments in the treatment of advanced bladder cancer.
    Urol Oncol. 2018 Jan 26. pii: S1078-1439(17)30647.
    >> Share

  39. HUPE MC, Vahlensieck W, Ozimek T, Struck JP, et al
    Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients.
    Urol Oncol. 2018 Jan 21. pii: S1078-1439(17)30643.
    >> Share

  40. GUO CC, Al-Ahmadie HA, Flaig TW, Kamat AM, et al
    Contribution of bladder cancer pathology assessment in planning clinical trials.
    Urol Oncol. 2018 Jan 29. pii: S1078-1439(18)30001.
    >> Share

  41. SCHROECK FR, Smith N, Shelton JB
    Implementing risk-aligned bladder cancer surveillance care.
    Urol Oncol. 2018 Jan 26. pii: S1078-1439(17)30645.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016